Emergent garners $29 million for new anthrax vaccine

first_img Sep 9 CIDRAP News story “HHS funds work on new anthrax antitoxin” Sep 26, 2008 (CIDRAP News) – Emergent BioSolutions announced today that it has received a $29.7 million contract from the federal government to continue work on another of its next-generation anthrax vaccine candidates. A next-generation anthrax vaccine would help the US military more easily inoculate troops. Soldiers in high-risk areas such as the Middle East typically receive six doses of BioThrax over 18 months, followed by annual boosters. The military has said a next-generation anthrax vaccine should ideally require fewer doses and have fewer side effects. Daniel J. Abdun-Nabi, Emergent’s president and chief operating officer, said in the statement that the grant is encouraged by federal support for its AV7909 anthrax vaccine candidate. “We look forward to continuing to work with the US government to advance all aspects of AV7909, as it pursues a multi-prong approach in responding to the ongoing threat of bioterrorism,” he said. On Sep 3, Emergent announced that it had won a $24.3 million federal contract for an anthrax monoclonal antibody treatment called AVP-21D9. In its statement today the company said it was also developing a polyclonal anthrax immunoglobulin candidate for intravenous treatment for patients who have anthrax infections. Emergent’s AV7909 anthrax vaccine consists of BioThrax (also known as Anthrax Vaccine Adsorbed), plus an adjuvant called CPG 7909, licensed from Pfizer, Inc. A clinical trial of CPG 7909 added to BioThrax showed that anti-protective antigen (PA) titers increased sixfold and reduced the time to peak response from 6 weeks to 3 weeks compared with BioThrax alone, Emergent said in its statement. Also, the two doses of AV7909 elicited the same anti-PA antibody levels as three doses of BioThrax.center_img See also: Sep 26 Emergent BioSolutions press release Of the 3-year contract, $24.9 million will cover the manufacturing of clinical lots, nonclinical safety and efficacy studies, and stability studies to determine if the vaccine can be stored without refrigeration, which is a key requirement for the new vaccine, Emergent said. The remaining $4.8 million would fund a phase 1 clinical trial if the company and the government exercise that option. Emergent, based in Rockville, Md., announced the contract from the Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID) in a press release today. The company makes BioThrax, the nation’s only licensed anthrax vaccine, and is also developing a recombinant anthrax vaccine and an anthrax monoclonal antibody to block the anthrax toxin.last_img read more

RCCF Raised $1.25 Million in 2015

first_imgRIPLEY COUNTY, Ind. — 2015 was a successful year for the Ripley County Community Foundation.In August 2014 Lilly Endowment announced its sixth Giving Indiana Funds for Tomorrow initiative.Through Giving Indiana Funds for Tomorrow, Lilly Endowment matched $500,000 in donations to the Ripley County Community Foundation.As a result of this opportunity, $1.25 million were added to the Foundation’s assets.The Board of Directors were overwhelmed by the support the Ripley County Community Foundation received in response to Lilly Endowment’s initiative.More than 1,500 individuals and businesses donated to the cause, with the youngest donor being 5 years old and the oldest donor being well into her 90’s.In responding to the challenge, donors created 21 new funds, which honor loved ones, businesses and non-profit organizations.last_img read more

Other Sports India Open Badminton to be held in Indra Gandhi Stadium for first time

first_img“Historically India has registered good results in this tournament and I am confident our players will repeat the feat this year too; especially playing at a new and historic venue like Indira Gandhi Stadium,” BAI President Himanta Biswa Sarma said.The tournament has evolved a long way since its inception in 2008. The first three editions of the India Open, then a Grand Prix Gold level tournament of the BWF tournament structure were hosted in Hyderabad. It was upgraded later to a BWF Superseries Tournament in 2011 and since then India Open is part of the World Tour and hosted at the National Capital.With the Olympic Qualification starting later this year; this year’s India Open will see a host of top players from world badminton trying to amass as many ranking points possible to guarantee a direct entry for the Tokyo 2020 Olympics. For all the Latest Sports News News, Other Sports News, Download News Nation Android and iOS Mobile Apps. New Delhi: India Open will have a new address this time with Indira Gandhi International Stadium (IGI) set to host the ninth edition of the World Tour Super 500 badminton tournament from March 26 to 31. After eight successful years, the USD 350,000 tournament will return for its ninth edition with the best names in the business descending on the capital for the event.This marque tournament was previously held at the Siri Fort Sports Complex for the last seven years. The Indira Gandhi International Stadium (IGI) in the past has hosted landmark sports events like the 1982 Asian Games and recently, the AIBA Women’s World Boxing Championships. All the matches will be played at the K.D Jadhav Indoor Hall located within the IGI stadium. highlights India Open will have a new address this time with Indira Gandhi International Stadium.The tournament was incarnated in the year 2008.The next Olympics will be played in Tokyo in 2020. last_img read more